CRL stock represents the common equity shares of Charles River Laboratories International, Inc., which are publicly traded on the New York Stock Exchange and included as a constituent of the S&P 500 index. Institutional asset managers, mutual funds, and retail investors buy and sell CRL shares to gain financial exposure to the contract research, pharmaceutical outsourcing, and biotechnology services sector.